Vanguard Group
EW icon

Vanguard Group’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.47B Buy
69,997,629
+798,801
+1% +$62.5M 0.09% 213
2025
Q1
$5.02B Buy
69,198,828
+66,792
+0.1% +$4.84M 0.09% 213
2024
Q4
$5.12B Buy
69,132,036
+6,537,494
+10% +$484M 0.09% 201
2024
Q3
$4.13B Buy
62,594,542
+9,018,528
+17% +$595M 0.07% 267
2024
Q2
$4.95B Buy
53,576,014
+611,620
+1% +$56.5M 0.1% 185
2024
Q1
$5.06B Buy
52,964,394
+600,994
+1% +$57.4M 0.1% 189
2023
Q4
$3.99B Buy
52,363,400
+729,984
+1% +$55.7M 0.09% 230
2023
Q3
$3.58B Buy
51,633,416
+325,808
+0.6% +$22.6M 0.09% 227
2023
Q2
$4.84B Sell
51,307,608
-443,619
-0.9% -$41.8M 0.11% 155
2023
Q1
$4.28B Buy
51,751,227
+191,836
+0.4% +$15.9M 0.11% 171
2022
Q4
$3.85B Buy
51,559,391
+648,287
+1% +$48.4M 0.1% 193
2022
Q3
$4.21B Buy
50,911,104
+604,269
+1% +$49.9M 0.12% 155
2022
Q2
$4.78B Buy
50,306,835
+581,969
+1% +$55.3M 0.13% 135
2022
Q1
$5.85B Buy
49,724,866
+648,217
+1% +$76.3M 0.14% 121
2021
Q4
$6.36B Buy
49,076,649
+269,987
+0.6% +$35M 0.14% 116
2021
Q3
$5.53B Buy
48,806,662
+497,212
+1% +$56.3M 0.14% 123
2021
Q2
$5B Sell
48,309,450
-159,126
-0.3% -$16.5M 0.12% 139
2021
Q1
$4.05B Buy
48,468,576
+120,891
+0.3% +$10.1M 0.11% 158
2020
Q4
$4.41B Sell
48,347,685
-493,541
-1% -$45M 0.13% 137
2020
Q3
$3.9B Sell
48,841,226
-587,284
-1% -$46.9M 0.13% 140
2020
Q2
$3.42B Buy
49,428,510
+32,751,525
+196% +$2.26B 0.12% 153
2020
Q1
$3.15B Buy
16,676,985
+415,283
+3% +$78.3M 0.13% 142
2019
Q4
$3.79B Buy
16,261,702
+158,853
+1% +$37.1M 0.13% 147
2019
Q3
$3.54B Buy
16,102,849
+124,338
+0.8% +$27.3M 0.13% 150
2019
Q2
$2.95B Sell
15,978,511
-2,893,106
-15% -$534M 0.11% 180
2019
Q1
$3.61B Sell
18,871,617
-2,985,042
-14% -$571M 0.14% 130
2018
Q4
$3.35B Buy
21,856,659
+371,674
+2% +$56.9M 0.15% 122
2018
Q3
$3.74B Buy
21,484,985
+25,275
+0.1% +$4.4M 0.15% 121
2018
Q2
$3.12B Buy
21,459,710
+163,747
+0.8% +$23.8M 0.13% 139
2018
Q1
$2.97B Sell
21,295,963
-33,036
-0.2% -$4.61M 0.13% 143
2017
Q4
$2.4B Buy
21,328,999
+276,381
+1% +$31.2M 0.11% 191
2017
Q3
$2.3B Buy
21,052,618
+304,049
+1% +$33.2M 0.11% 187
2017
Q2
$2.45B Buy
20,748,569
+406,901
+2% +$48.1M 0.12% 163
2017
Q1
$1.91B Buy
20,341,668
+505,725
+3% +$47.6M 0.1% 208
2016
Q4
$1.86B Buy
19,835,943
+560,670
+3% +$52.5M 0.1% 197
2016
Q3
$2.32B Buy
19,275,273
+479,089
+3% +$57.8M 0.14% 144
2016
Q2
$1.87B Buy
18,796,184
+134,432
+0.7% +$13.4M 0.12% 179
2016
Q1
$1.65B Buy
18,661,752
+345,655
+2% +$30.5M 0.11% 194
2015
Q4
$1.45B Buy
18,316,097
+9,283,833
+103% +$733M 0.1% 212
2015
Q3
$1.28B Sell
9,032,264
-318,834
-3% -$45.3M 0.09% 229
2015
Q2
$1.33B Buy
9,351,098
+217,449
+2% +$31M 0.09% 226
2015
Q1
$1.3B Buy
9,133,649
+468,564
+5% +$66.8M 0.09% 243
2014
Q4
$1.1B Buy
8,665,085
+273,885
+3% +$34.9M 0.08% 271
2014
Q3
$857M Buy
8,391,200
+963,527
+13% +$98.4M 0.07% 321
2014
Q2
$638M Sell
7,427,673
-25,729
-0.3% -$2.21M 0.05% 429
2014
Q1
$553M Buy
7,453,402
+91,963
+1% +$6.82M 0.05% 453
2013
Q4
$484M Sell
7,361,439
-13,866
-0.2% -$912K 0.04% 486
2013
Q3
$514M Sell
7,375,305
-47,281
-0.6% -$3.29M 0.05% 428
2013
Q2
$499M Buy
+7,422,586
New +$499M 0.05% 410